Horizon Therapeutics PLC
Change company Symbol lookup
Select an option...
HZNP Horizon Therapeutics PLC
SCL Stepan Co
GRWG GrowGeneration Corp
ROG Rogers Corp
ALB Albemarle Corp
DD Dupont De Nemours Inc
SMG Scotts Miracle-Gro Co
MTX Minerals Technologies Inc
HUN Huntsman Corp
PPG PPG Industries Inc
Go

Health Care : Biotechnology | Mid Cap Growth
Based in Ireland
Company profile

Horizon Therapeutics plc is a global biotechnology company. The Company is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The Company's portfolio is composed of approximately 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. The Company operates through two segments: orphan segment and the inflammation segment. The orphan segment includes medicines, such as TEPEZZA (teprotumumab-trbw), KRYSTEXXA (pegloticase injection), RAVICTI (glycerol phenylbutyrate), PROCYSBI (cysteamine bitartrate), UPLIZNA (inebilizumab-cdon) injection, ACTIMMUNE (interferon gamma-1b) injection, BUPHENYL (sodium phenylbutyrate) tablets and powder, and QUINSAIR (levofloxacin) solution. The inflammation segment includes medicines, such as PENNSAID (diclofenac sodium topical solution), RAYOS (prednisone), VIMOVO (naproxen), and DUEXIS (ibuprofen).

Closing Price
$78.28
Day's Change
0.75 (0.97%)
Bid
--
Ask
--
B/A Size
--
Day's High
78.45
Day's Low
77.56
Volume
(Light)
Volume:
534,719

10-day average volume:
1,658,583
534,719
  • Prev Close
    77.53
  • Today's Open
    77.85
  • Day's Range
    77.56-78.45
  • Avg Vol (10-day)
    1.7M
  • Last (time)
    12:59p ET 11/25/22
  • Last (size)
    7
  • 52-Wk Range
    57.84 - 117.49
    LowHigh
  • (04/21/22 - 09/01/22)
    35.34%
  • 42.7%
  • Market Cap
    17.7B
  • Shares Outstanding
    226.6M
  • 3.24
  • 24.18x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.1
  • 94.66
  • (% of float 11/15/22)
    3.12

Latest News

November 23, 2022
9:40 am ET
Zacks
6:00 am ET
BusinessWire
November 16, 2022
8:15 am ET
BusinessWire
8:00 am ET
BusinessWire
November 10, 2022
8:00 am ET
BusinessWire
November 08, 2022
10:00 am ET
BusinessWire
November 05, 2022
10:00 am ET
BusinessWire
November 02, 2022
7:00 am ET
BusinessWire
November 01, 2022
9:00 am ET
BusinessWire
October 27, 2022
8:30 am ET
PR Newswire
8:30 am ET
BusinessWire
October 26, 2022
8:00 am ET
BusinessWire
October 22, 2022
10:30 am ET
BusinessWire
October 13, 2022
8:00 am ET
BusinessWire
October 12, 2022
8:00 am ET
BusinessWire
October 06, 2022
10:03 am ET
BusinessWire
8:00 am ET
BusinessWire
October 02, 2022
11:15 am ET
BusinessWire
September 29, 2022
8:00 am ET
BusinessWire
September 22, 2022
8:04 am ET
BusinessWire
September 21, 2022
8:04 am ET
BusinessWire
7:30 am ET
PR Newswire
September 19, 2022
8:00 am ET
BusinessWire
September 16, 2022
9:00 am ET
BusinessWire
September 14, 2022
8:00 am ET
BusinessWire
September 13, 2022
8:30 am ET
BusinessWire
September 12, 2022
8:00 am ET
BusinessWire
September 09, 2022
8:00 am ET
BusinessWire
September 08, 2022
8:03 am ET
BusinessWire
August 31, 2022
9:03 am ET
BusinessWire
August 04, 2022
8:45 am ET
MarketWatch
June 14, 2022
10:52 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.